(Q42242323)

English

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

scientific article published on 29 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway (English)

1 reference

Europe PubMed Central

19 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Anneke Steens

1

0 references

author name string

Marianne A Riise Bergsaker

2

1 reference

Europe PubMed Central

19 October 2017

Ingeborg S Aaberge

3

1 reference

Europe PubMed Central

19 October 2017

Karin Rønning

4

1 reference

Europe PubMed Central

19 October 2017

Didrik F Vestrheim

5

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

29 October 2013

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

31

1 reference

Europe PubMed Central

19 October 2017

6232-6238

1 reference

Europe PubMed Central

19 October 2017

52

1 reference

Europe PubMed Central

19 October 2017

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Vaccination against colonizing bacteria with multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Measurement of Diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Review on the immunogenicity and safety of PCV-13 in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.032

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.10.032

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42242323&oldid=1939764480"